|
|
Volumn 24, Issue 4, 2006, Pages 327-333
|
|
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors
d
a
d
NONE
|
|
Author keywords
CS 682; Pharmacokinetics; Phase I
|
|
Indexed keywords
1 (2 C CYANO 2 DEOXY BETA D ARABINO PENTOFURANOSYL) N4 PALMITOYLCYTOSINE;
1 (2 C CYANO 2 DEOXY BETA D ARABINO PENTOFURANOSYL)CYTOSINE;
1 (2 CYANO 2 DEOXY BETA D ARABINO PENTOFURANOSYL) N4 URIDINE;
2' CYANO 2' DEOXY 4 N PALMITOYLCYTARABINE;
ANTIMETABOLITE;
ANTINEOPLASTIC AGENT;
CYTIDINE DEAMINASE;
DEOXYCYTIDINE;
UNCLASSIFIED DRUG;
ADULT;
ADVANCED CANCER;
AGED;
ALOPECIA;
ANEMIA;
ANOREXIA;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
ASTHENIA;
BLOOD TOXICITY;
BREAST CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COLORECTAL CANCER;
DEHYDRATION;
DIARRHEA;
DISEASE SEVERITY;
DRUG ABSORPTION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG RESPONSE;
DRUG STRUCTURE;
ENZYME ACTIVITY;
FEMALE;
HOSPITALIZATION;
HUMAN;
HUMAN TISSUE;
LEUKOPENIA;
LUNG CARCINOMA;
MALE;
MAXIMUM TOLERATED DOSE;
NAUSEA;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
SOLID TUMOR;
STOMATITIS;
THROMBOCYTOPENIA;
VOMITING;
ADMINISTRATION, ORAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC AGENTS;
ARABINONUCLEOSIDES;
CYTOSINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM STAGING;
NEOPLASMS;
|
|
EID: 33646508837
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1007/s10637-006-5392-0 Document Type: Article |
|
Times cited : (15)
|
|
References (8)
|
